![James W. Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of James W. Kim
Former positions of James W. Kim
Companies | Position | Start | End |
---|---|---|---|
SCIGEN LIMITED | Director/Board Member | 2016-04-17 | 2017-02-08 |
Chief Executive Officer | 2016-04-17 | 2017-02-08 | |
BIOTON S.A. | Corporate Officer/Principal | - | - |
Training of James W. Kim
University of Wisconsin | Doctorate Degree |
Trinity International University | Undergraduate Degree |
Statistics
International
United States | 3 |
Singapore | 2 |
Poland | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BIOTON S.A. | Health Technology |
Private companies | 1 |
---|---|
SciGen Pte Ltd.
![]() SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- James W. Kim
- Experience